30 results on '"Furie, Bruce"'
Search Results
2. List of Contributors
- Author
-
Andrews, Robert K., primary, Aster, Richard H., additional, Atkinson, Ben T, additional, Barnard, Marc R., additional, Bavry, Anthony A., additional, Bayer, Arnold S., additional, Beaulieu, Lea M., additional, Berndt, Michael C., additional, Berny-Lang, Michelle A., additional, Bhatt, Deepak L., additional, Bizzaro, Nicola, additional, Bledzka, Kamila, additional, Bouchard, Beth A., additional, Brass, Lawrence F., additional, Bray, Paul F., additional, Briggs, Carol, additional, Bussel, James B., additional, Cattaneo, Marco, additional, Chakravorty, Subarna, additional, Chong, Beng H., additional, Clemetson, Jeannine, additional, Clemetson, Kenneth J., additional, Coller, Barry S., additional, Covic, Lidija, additional, Davì, Giovanni, additional, del Zoppo, Gregory J., additional, Dowling, Mark R., additional, Dubois, Christophe, additional, Eisert, Wolfgang G., additional, Evangelista, Virgilio, additional, Flaumenhaft, Robert, additional, Freedman, Jane E., additional, Freedman, John, additional, Frelinger, Andrew L., additional, Furie, Barbara C., additional, Furie, Bruce, additional, Gardiner, Chris, additional, Gawaz, Meinrad, additional, Geisler, Tobias, additional, Greinacher, Andreas, additional, Gurbel, Paul A., additional, Harrison, Paul, additional, Hartwig, John H., additional, Hayward, Catherine P.M., additional, Hughes, Craig E., additional, Ikeda, Yasuo, additional, Israels, Sara J., additional, Italiano, Joseph E., additional, Jackson, Shaun, additional, Jain, Shashank, additional, Jones, Chris I., additional, Josefsson, Emma C., additional, Kaplan, Cécile, additional, Kile, Benjamin T., additional, Kimura, Yukio, additional, Klement, Giannoula Lakka, additional, Kolandaivelu, Kumaran, additional, Kuliopulos, Athan, additional, Kuter, David J., additional, Lambert, Michelle P., additional, Langer, Harald F., additional, Lebois, Marion, additional, Levin, Jack, additional, Lordkipanidzé, Marie, additional, Ma, Yan-Qing, additional, Mannucci, Pier Mannuccio, additional, McCrae, Keith R., additional, Merrill-Skoloff, Glenn, additional, Michelson, Alan D., additional, Moffat, Karen A., additional, Mutch, Nicola J., additional, Newman, Debra K., additional, Newman, Peter E., additional, Ni, Heyu, additional, Nieuwland, Rienk, additional, Ouwehand, Willem H., additional, Parsons, Jeremy, additional, Patrono, Carlo, additional, Perrotta, Peter L., additional, Pesho, Michelle M., additional, Plow, Edward F., additional, Politt, Alice Y., additional, Poncz, Mortimer, additional, Poon, Man-Chiu, additional, Provost, Patrick, additional, Psaila, Bethan, additional, Rao, A. Koneti, additional, Rinder, Henry M., additional, Roberts, Irene A.G., additional, Rondina, Matthew T., additional, Ruggeri, Zaverio M., additional, Santilli, Francesca, additional, Schwertz, Hansjörg, additional, Shai, Ela, additional, Silveira, Jay R., additional, Smith, Brian R., additional, Smith, Matthew C., additional, Smyth, Susan S., additional, Snyder, Edward L., additional, Sobel, Michael, additional, Soranzo, Nicole, additional, Stalker, Timothy J., additional, Sturk, Auguste, additional, Sudo, Toshiki, additional, Sullivan, Spencer, additional, Tantry, Udaya S., additional, Tefferi, Ayalew, additional, Tracy, Paul B., additional, Tsai, Han-Mou, additional, van der Pol, Edwin, additional, Varon, David, additional, Vazzana, Natale, additional, Vieira-de-Abreu, Adriana, additional, Wannemacher, Kenneth, additional, Ware, Jerry, additional, Warkentin, Theodore E., additional, Watson, Steve P., additional, Weyrich, Andrew S., additional, White, James G., additional, Wilcox, David A., additional, Yeaman, Michael R., additional, Zhang, Ping, additional, Zhu, Li, additional, and Zimmerman, Guy A., additional
- Published
- 2013
- Full Text
- View/download PDF
3. Real-Time In Vivo Imaging of Platelets During Thrombus Formation
- Author
-
Dubois, Christophe, primary, Atkinson, Ben, additional, Furie, Barbara, additional, and Furie, Bruce, additional
- Published
- 2007
- Full Text
- View/download PDF
4. Contributors
- Author
-
Afshar-Kharghan, Vahid, primary, Agah, Ramtin, additional, Andrews, Robert K., additional, Aster, Richard H., additional, Atkinson, Ben, additional, Awtry, Eric H., additional, Bahou, Wadie F., additional, Barnard, Marc R., additional, Bavry, Anthony A., additional, Bayer, Arnold S., additional, Becker, Richard C., additional, Bergmeier, Wolfgang, additional, Berndt, Michael C., additional, Bhatt, Deepak L., additional, Bizzaro, Nicola, additional, Blajchman, Morris A., additional, Bouchard, Beth A., additional, Brass, Lawrence F., additional, Bray, Paul F., additional, Briggs, Carol, additional, Brill, Alexander, additional, Bussel, James B., additional, Butenas, Saulius, additional, Cattaneo, Marco, additional, Chong, Beng H., additional, Clemetson, Kenneth J., additional, Clemetson, Jeannine M., additional, Coller, Barry S., additional, Crawford, Lawrence E., additional, de Groot, Philip G., additional, del Zoppo, Gregory J., additional, Dubois, Christophe, additional, Eisert, Wolfgang G., additional, FitzGerald, Garret A., additional, Francis, John L., additional, Freedman, Jane E., additional, Freedman, John, additional, Frelinger III, A.L., additional, Fries, Susanne, additional, Furie, Barbara C., additional, Furie, Bruce, additional, Furman, Mark I., additional, García-Alonso, Ángel, additional, Goldschmidt, Pascal J., additional, Grosser, Tilo, additional, Gurguis, George N.M., additional, Harrison, Paul, additional, Hartwig, John H., additional, Ike da, Yas uo, additional, Israels, Sara J., additional, Italiano, Joseph E., additional, Jennings, Lisa K., additional, Kaplan, Cécile, additional, Karpatkin, Simon, additional, Keeling, David M., additional, Kimura, Yukio, additional, Kurkjian, Carla D., additional, Kuter, David J., additional, Lambert, Michele P., additional, Lee, David H., additional, Levin, Jack, additional, Li, Qiao-Xin, additional, Li, Zongdong, additional, Lind, Stuart E., additional, Linden, Matthew D., additional, Lopes, Neuza H.M., additional, López, José A., additional, Loscalzo, Joseph, additional, Ma, Yan-qing, additional, Machin, Samuel J., additional, Mann, Kenneth G., additional, Mannucci, Pier Mannuccio, additional, Maron, Bradley A., additional, Masters, Colin L., additional, McCrae, Keith R., additional, McEver, Rodger P., additional, Menart, Barbara, additional, Michelson, Alan D., additional, Moake, Joel, additional, Murray, Neil, additional, Nardi, Michael A., additional, Newman, Debra K., additional, Newman, Peter J., additional, Nierodzik, Mary Lynn, additional, Nieuwland, Rienk, additional, Novinska, Melanie, additional, Nurden, Alan T., additional, Nurden, Paquita, additional, Perrotta, Peter L., additional, Pesho, Michelle M., additional, Plow, Edward F., additional, Poncz, Mortimer, additional, Poon, Man-Chiu, additional, Prévost, Nicholas, additional, Rao, A. Koneti, additional, Rathore, Vipul, additional, Reed, Guy L., additional, Rex, Sybille, additional, Rinder, Christine S., additional, Rinder, Henry M., additional, Roberts, Irene, additional, Ruggeri, Zaverio M., additional, Savage, Brian, additional, Savion, Naphtali, additional, Senis, Yotis, additional, Shattil, Sanford J., additional, Sixma, Jan J., additional, Smith, Brian R., additional, Snyder, Edward L., additional, Sobel, Michael, additional, Stalker, Timothy J., additional, Steinhubl, Steven R., additional, Stratmann, Bernd, additional, Sturk, Augueste, additional, Sudo, Toshiki, additional, Tef feri, Aya lew, additional, Tomlinson, Michael G., additional, Topol, Eric J., additional, Tracy, Paula B., additional, Tschoepe, Diethelm, additional, Varon, David, additional, Vijayan, K. Vinod, additional, Wagner, Denisa D., additional, Watson, Steve P., additional, White, II, Gilbert C., additional, White, James G., additional, McCabe White, Melanie, additional, Wilcox, David A., additional, Woulfe, Donna S., additional, Yeaman, Michael R., additional, and Zhu, Li, additional
- Published
- 2007
- Full Text
- View/download PDF
5. NMR structures for the membrane binding gla domain of blood coagulation factor IX
- Author
-
Baleja, James D., primary, Freedman, Steven J., additional, Furie, Barbara C., additional, and Furie, Bruce, additional
- Published
- 1996
- Full Text
- View/download PDF
6. [25] Role of propeptide in vitamin K-dependent γ-carboxylation
- Author
-
Kotkow, Karen J., primary, Roth, David A., additional, Porter, Thomas J., additional, Furie, Barbara C., additional, and Furie, Bruce, additional
- Published
- 1993
- Full Text
- View/download PDF
7. Staphylococcal Nuclease, a Calcium-Binding Protein: Path to the Vitamin K-Dependent Blood Coagulation Proteins
- Author
-
FURIE, BRUCE, primary
- Published
- 1984
- Full Text
- View/download PDF
8. [27] PADGEM protein
- Author
-
Berman, Cindy L., primary, Yeo, Erik L., additional, Furie, Barbara C., additional, and Furie, Bruce, additional
- Published
- 1989
- Full Text
- View/download PDF
9. [16] Coagulant protein of Russell's viper venom
- Author
-
Furie, Barbara C., primary and Furie, Bruce, additional
- Published
- 1976
- Full Text
- View/download PDF
10. γ-Carboxyglutamic Acid-Containing Ca2+-Binding Proteins
- Author
-
FURIE, BARBARA C., primary, BOROWSKI, MARIANNE, additional, KEYT, BRUCE, additional, and FURIE, BRUCE, additional
- Published
- 1982
- Full Text
- View/download PDF
11. [75] Purification of proteins involved in Ca(II)-dependent protein-protein interactions (coagulant protein of Russell's viper venom)
- Author
-
Furie, Barbara C., primary and Furie, Bruce, additional
- Published
- 1974
- Full Text
- View/download PDF
12. [5] Conformation-specific antibodies: approach to the study of the vitamin K-dependent blood coagulation proteins
- Author
-
Furie, Bruce, primary, Blanchard, Rita A., additional, Robison, David J., additional, Tai, Mindy M., additional, and Furie, Barbara C., additional
- Published
- 1982
- Full Text
- View/download PDF
13. Vascular thiol isomerases.
- Author
-
Flaumenhaft R and Furie B
- Subjects
- Animals, Blood Vessels pathology, Hemostasis, Humans, Models, Biological, Oxidation-Reduction, Thrombosis enzymology, Thrombosis pathology, Blood Vessels enzymology, Protein Disulfide-Isomerases metabolism
- Abstract
Thiol isomerases are multifunctional enzymes that influence protein structure via their oxidoreductase, isomerase, and chaperone activities. These enzymes localize at high concentrations in the endoplasmic reticulum of all eukaryotic cells where they serve an essential function in folding nascent proteins. However, thiol isomerases can escape endoplasmic retention and be secreted and localized on plasma membranes. Several thiol isomerases including protein disulfide isomerase, ERp57, and ERp5 are secreted by and localize to the membranes of platelets and endothelial cells. These vascular thiol isomerases are released following vessel injury and participate in thrombus formation. Although most of the activities of vascular thiol isomerases that contribute to thrombus formation are yet to be defined at the molecular level, allosteric disulfide bonds that are modified by thiol isomerases have been described in substrates such as αIIbβ3, αvβ3, GPIbα, tissue factor, and thrombospondin. Vascular thiol isomerases also act as redox sensors. They respond to the local redox environment and influence S-nitrosylation of surface proteins on platelets and endothelial cells. Despite our rudimentary understanding of the mechanisms by which thiol isomerases control vascular function, the clinical utility of targeting them in thrombotic disorders is already being explored in clinical trials., (© 2016 by The American Society of Hematology.)
- Published
- 2016
- Full Text
- View/download PDF
14. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.
- Author
-
Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S, Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP, Ballmaier M, Baynam G, Bermejo E, Bertoli M, Bray PF, Bury L, Cattaneo M, Collins P, Daugherty LC, Favier R, French DL, Furie B, Gattens M, Germeshausen M, Ghevaert C, Goodeve AC, Guerrero JA, Hampshire DJ, Hart DP, Heemskerk JW, Henskens YM, Hill M, Hogg N, Jolley JD, Kahr WH, Kelly AM, Kerr R, Kostadima M, Kunishima S, Lambert MP, Liesner R, López JA, Mapeta RP, Mathias M, Millar CM, Nathwani A, Neerman-Arbez M, Nurden AT, Nurden P, Othman M, Peerlinck K, Perry DJ, Poudel P, Reitsma P, Rondina MT, Smethurst PA, Stevenson W, Szkotak A, Tuna S, van Geet C, Whitehorn D, Wilcox DA, Zhang B, Revel-Vilk S, Gresele P, Bellissimo DB, Penkett CJ, Laffan MA, Mumford AD, Rendon A, Gomez K, Freson K, Ouwehand WH, and Turro E
- Subjects
- Case-Control Studies, DNA Copy Number Variations, Female, Genetic Association Studies methods, Humans, Male, Mutation, Polymorphism, Single Nucleotide, Sequence Analysis, DNA methods, Blood Platelet Disorders genetics, Genetic Predisposition to Disease, Hemorrhage genetics, High-Throughput Nucleotide Sequencing methods, Thrombosis genetics
- Abstract
Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often unavailable. Many specialized tests are usually required to reach a putative diagnosis and they are typically performed in a step-wise manner to control costs. This approach causes delays and a conclusive molecular diagnosis is often never reached, which can compromise treatment and impede rapid identification of affected relatives. To address this unmet diagnostic need, we designed a high-throughput sequencing platform targeting 63 genes relevant for BPDs. The platform can call single nucleotide variants, short insertions/deletions, and large copy number variants (though not inversions) which are subjected to automated filtering for diagnostic prioritization, resulting in an average of 5.34 candidate variants per individual. We sequenced 159 and 137 samples, respectively, from cases with and without previously known causal variants. Among the latter group, 61 cases had clinical and laboratory phenotypes indicative of a particular molecular etiology, whereas the remainder had an a priori highly uncertain etiology. All previously detected variants were recapitulated and, when the etiology was suspected but unknown or uncertain, a molecular diagnosis was reached in 56 of 61 and only 8 of 76 cases, respectively. The latter category highlights the need for further research into novel causes of BPDs. The ThromboGenomics platform thus provides an affordable DNA-based test to diagnose patients suspected of having a known inherited BPD., (© 2016 by The American Society of Hematology.)
- Published
- 2016
- Full Text
- View/download PDF
15. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis.
- Author
-
Passam FH, Lin L, Gopal S, Stopa JD, Bellido-Martin L, Huang M, Furie BC, and Furie B
- Subjects
- Animals, Blood Platelets metabolism, Blood Platelets pathology, Blotting, Western, Cells, Cultured, Endothelium, Vascular metabolism, Endothelium, Vascular pathology, Enzyme-Linked Immunosorbent Assay, Fibrin metabolism, Humans, Male, Mice, Mice, Inbred C57BL, Platelet Activation, Recombinant Proteins genetics, Recombinant Proteins metabolism, Surface Plasmon Resonance, Thrombosis enzymology, Thrombosis etiology, Disease Models, Animal, Integrin beta3 metabolism, Lasers adverse effects, Platelet Glycoprotein GPIIb-IIIa Complex metabolism, Protein Disulfide-Isomerases metabolism, Thrombosis pathology
- Abstract
Protein disulfide isomerase (PDI) and endoplasmic reticulum protein 57 (ERp57) are emerging as important regulators of thrombus formation. Another thiol isomerase, endoplasmic reticulum protein 5 (ERp5), is involved in platelet activation. We show here the involvement of ERp5 in thrombus formation using the mouse laser-injury model of thrombosis and a specific antibody raised against recombinant ERp5. Anti-ERp5 antibody inhibited ERp5-dependent platelet and endothelial cell disulfide reductase activity in vitro. ERp5 release at the thrombus site was detected after infusion of Alexa Fluor 488-labeled anti-ERp5 antibody at 0.05 μg/g body weight, a dose that does not inhibit thrombus formation. Anti-ERp5 at 3 μg/g body weight inhibited laser-induced thrombus formation in vivo by causing a 70% decrease in the deposition of platelets and a 62% decrease in fibrin accumulation compared to infusion of control antibody (P < .01). ERp5 binds to β3 integrin with an equilibrium dissociation constant (KD) of 21 µM, measured by surface plasmon resonance. The cysteine residues in the ERp5 active sites are not required for binding to β3 integrin. These results provide evidence for a novel role of ERp5 in thrombus formation, a function that may be mediated through its association with αIIbβ3., (© 2015 by The American Society of Hematology.)
- Published
- 2015
- Full Text
- View/download PDF
16. Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome.
- Author
-
Sharda A, Kim SH, Jasuja R, Gopal S, Flaumenhaft R, Furie BC, and Furie B
- Subjects
- Adenosine Diphosphate deficiency, Adenosine Diphosphate metabolism, Adenosine Diphosphate pharmacology, Animals, Apyrase metabolism, Apyrase pharmacology, Blood Platelets drug effects, Cell Degranulation, Disease Models, Animal, Endothelial Cells pathology, Exocytosis drug effects, Female, Fibrin biosynthesis, Hermanski-Pudlak Syndrome genetics, Human Umbilical Vein Endothelial Cells, Humans, Intracellular Signaling Peptides and Proteins antagonists & inhibitors, Intracellular Signaling Peptides and Proteins blood, Intracellular Signaling Peptides and Proteins genetics, Mice, Mice, Inbred C57BL, Mice, Knockout, Platelet Aggregation, Protein Disulfide-Isomerases blood, RNA, Small Interfering genetics, Thrombin metabolism, Vesicular Transport Proteins deficiency, Vesicular Transport Proteins genetics, Blood Platelets enzymology, Endothelial Cells enzymology, Hermanski-Pudlak Syndrome blood, Hermanski-Pudlak Syndrome enzymology, Protein Disulfide-Isomerases metabolism, Thrombosis blood, Thrombosis enzymology
- Abstract
Protein disulfide isomerase (PDI), secreted from platelets and endothelial cells after injury, is required for thrombus formation. The effect of platelet and endothelial cell granule contents on PDI-mediated thrombus formation was studied by intravital microscopy using a mouse model of Hermansky-Pudlak syndrome in which platelet dense granules are absent. Platelet deposition and fibrin generation were nearly absent, and extracellular PDI was significantly reduced in HPS6(-/-) mice after vascular injury. HPS6(-/-) platelets displayed impaired PDI secretion and impaired exocytosis of α granules, lysosomes, and T granules due to decreased sensitivity to thrombin, but these defects could be corrected by addition of subthreshold amounts of adenosine 5'-diphosphate (ADP). Human Hermansky-Pudlak syndrome platelets demonstrated similar characteristics. Infusion of wild-type platelets rescued thrombus formation in HPS6(-/-) mice. Human umbilical vein endothelial cells in which the HPS6 gene was silenced displayed impaired PDI secretion and exocytosis of Weibel-Palade bodies. Defective thrombus formation in Hermansky-Pudlak syndrome, associated with impaired exocytosis of residual granules in endothelial cells and platelets, the latter due to deficiency of ADP, is characterized by a defect in T granule secretion, a deficiency in extracellular PDI secretion, and impaired fibrin generation and platelet aggregation. Hermansky-Pudlak syndrome is an example of a hereditary disease whereby impaired PDI secretion contributes to a bleeding phenotype., (© 2015 by The American Society of Hematology.)
- Published
- 2015
- Full Text
- View/download PDF
17. How I treat poisoning with vitamin K antagonists.
- Author
-
Schulman S and Furie B
- Subjects
- Aged, Anticoagulants blood, Anticoagulants pharmacokinetics, Blood Coagulation Disorders complications, Female, Hemorrhage etiology, Humans, Male, Middle Aged, Prognosis, Rodenticides blood, Rodenticides pharmacokinetics, Anticoagulants poisoning, Blood Coagulation Disorders drug therapy, Hemorrhage drug therapy, Rodenticides poisoning, Vitamin K antagonists & inhibitors
- Abstract
Severe deficiency of vitamin K-dependent proteins in patients not maintained on vitamin K antagonists is most commonly associated with poisoning by or surreptitious ingestion of warfarin, warfarin-like anticoagulants, or potent rodenticides ("superwarfarins"), such as brodifacoum. Serious bleeding manifestations are common. Superwarfarins are 2 orders of magnitude more potent than warfarin and have a half-life measured in weeks. These rodenticides are readily available household environmental hazards and are sometimes consumed accidentally or as manifestations of psychiatric disease. Immediate diagnosis and proper therapy is critically important to minimize morbidity and mortality because this condition, affecting thousands of patients annually, is reversible. Treatment with large doses of oral vitamin K1, often over months to years, to maintain a near-normal prothrombin time can reverse the coagulopathy associated with superwarfarins. Although these patients initially present to various medical specialties, the hematologist is often consulted to offer the definitive diagnosis and proper therapy., (© 2015 by The American Society of Hematology.)
- Published
- 2015
- Full Text
- View/download PDF
18. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.
- Author
-
Proulle V, Furie RA, Merrill-Skoloff G, Furie BC, and Furie B
- Subjects
- Animals, Antiphospholipid Syndrome metabolism, Antiphospholipid Syndrome pathology, Autoantibodies blood, Autoantibodies immunology, Blood Platelets cytology, Blood Platelets metabolism, Blotting, Western, Cell Membrane metabolism, Cells, Cultured, Endothelium cytology, Endothelium metabolism, Fibrin metabolism, Fibrinogen metabolism, Humans, Intercellular Adhesion Molecule-1 metabolism, Mice, Mice, Inbred C57BL, Platelet Activation, Thrombosis metabolism, Thrombosis pathology, beta 2-Glycoprotein I immunology, Antibodies, Antiphospholipid blood, Antiphospholipid Syndrome immunology, Blood Platelets immunology, Disease Models, Animal, Endothelium immunology, Thrombosis immunology, beta 2-Glycoprotein I metabolism
- Abstract
Antiphospholipid syndrome (APS) is defined by thrombosis, fetal loss, and the presence of antiphospholipid antibodies, including anti-β2-glycoprotein-1 autoantibodies (anti-β2GP1) that have a direct role in the pathogenesis of thrombosis in vivo. The cellular targets of the anti-β2GP1 autoantibody/β2GP1 complex in vivo were studied using a laser-induced thrombosis model of APS in a live mouse and human anti-β2GP1 autoantibodies affinity-purified from APS patients. Cell binding of fluorescently labeled β2GP1 and anti-β2GP1 autoantibodies revealed their colocalization on the platelet thrombus but not the endothelium. Anti-β2GP1 autoantibodies enhanced platelet activation, monitored by calcium mobilization, and endothelial activation, monitored by intercellular adhesion molecule-1 expression. When eptifibatide was infused to block platelet thrombus formation, enhanced fibrin generation and endothelial cell activation were eliminated. Thus, the anti-β2GP1 autoantibody/β2GP1 complex binds to the thrombus, enhancing platelet activation, and platelet secretion leads to enhanced endothelium activation and fibrin generation. These results lead to a paradigm shift away from the concept that binding of the anti-β2GP1 autoantibody/β2GP1 complex activates both endothelial cells and platelets toward one in which activation of platelets in response to anti-β2GP1 autoantibody/β2GP1 complex binding leads to subsequent enhanced endothelium activation and fibrin generation., (© 2014 by The American Society of Hematology.)
- Published
- 2014
- Full Text
- View/download PDF
19. Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins.
- Author
-
Cho J, Kennedy DR, Lin L, Huang M, Merrill-Skoloff G, Furie BC, and Furie B
- Subjects
- Animals, Arterioles enzymology, Arterioles injuries, Blood Coagulation physiology, Blood Platelets metabolism, Bone Marrow Transplantation, CHO Cells, Cricetinae, Extracellular Space enzymology, Integrin alphaVbeta3 metabolism, Mice, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Mutant Strains, Microscopy, Video, Muscle, Skeletal blood supply, Platelet Glycoprotein GPIIb-IIIa Complex metabolism, Transplantation Chimera, Blood Platelets enzymology, Endothelial Cells enzymology, Integrin beta3 metabolism, Protein Disulfide-Isomerases metabolism, Thrombosis metabolism
- Abstract
Extracellular protein disulfide isomerase (PDI) is required for platelet thrombus formation and fibrin generation after arteriolar wall injury in live mice. PDI is secreted from platelets and endothelial cells on cellular activation, but the mechanism of capture of secreted PDI within the injured vasculature is unknown. We establish that, like the endothelial β3 integrin α(V)β(3), the platelet integrin α(IIb)β(3) binds PDI. PDI also binds to recombinant β3. Using intravital microscopy, we demonstrate that PDI accumulation at the site of laser-induced arteriolar wall injury is markedly reduced in β3-null (β3(-/-)) mice, and neither a platelet thrombus nor fibrin is generated at the vessel injury site. The absence of fibrin after vascular injury in β3(-/-) mice is because of the absence of extracellular PDI. To evaluate the relative importance of endothelial α(V)β(3) versus platelet α(IIb)β(3) or α(V)β(3), we performed reciprocal bone marrow transplants on wild-type and β3(-/-) mice. PDI accumulation and platelet thrombus formation were markedly decreased after vessel injury in wild-type mice transplanted with β3(-/-) bone marrow or in β3(-/-) mice transplanted with wild-type bone marrow. These results indicate that both endothelial and platelet β3 integrins contribute to extracellular PDI binding at the vascular injury site.
- Published
- 2012
- Full Text
- View/download PDF
20. β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.
- Author
-
Arad A, Proulle V, Furie RA, Furie BC, and Furie B
- Subjects
- Adult, Animals, Antiphospholipid Syndrome blood, Arteries pathology, Autoantibodies isolation & purification, Female, Humans, Male, Mice, Mice, Inbred C57BL, Middle Aged, Thrombosis metabolism, Thrombosis pathology, beta 2-Glycoprotein I metabolism, Antiphospholipid Syndrome immunology, Autoantibodies adverse effects, Disease Models, Animal, Thrombosis etiology, beta 2-Glycoprotein I immunology
- Abstract
Antiphospholipid syndrome is characterized by thrombosis, recurrent fetal loss, and the presence of the lupus anticoagulant, anticardiolipin antibodies, or anti-β(2)-glycoprotein-1 (anti-β(2)-GP1) antibodies. Although anti-β(2)-GP1 antibodies have been documented as a biomarker for diagnosis of antiphospholipid syndrome, their direct role in the pathogenesis of thrombosis is unknown. We have demonstrated using intravital microscopy that anti-β(2)-GP1 autoantibodies purified from the sera of patients with antiphospholipid syndrome complicated by thrombosis greatly amplify thrombus size after laser-induced vessel wall injury in live mice. Anti-β(2)-GP1 autoantibodies from 3 patients with antiphospholipid syndrome were affinity-purified using human β(2)-GP1 bound to agarose. The effects of purified anti-β(2)-GP1 IgG autoantibodies, of anti-β(2)-GP1-depleted IgG, and of IgG from normal human sera on thrombus formation were measured in mice after arterial injury in the cremaster muscle. Before injury, purified anti-β(2)-GP1 IgG autoantibodies, anti-β(2)-GP1 antibody-depleted IgG, or IgG from normal human sera were infused. Increasing amounts of purified anti-β(2)-GP1 autoantibodies increased thrombus size in a dose-dependent manner, whereas neither anti-β(2)-GP1 antibody-depleted IgG nor IgG from normal serum affected thrombus size. These results indicate that anti-β(2)-GP1 IgG autoantibodies in antiphospholipid syndrome patient sera are not only a marker of antiphospholipid syndrome but are directly involved in the pathogenesis of thrombosis.
- Published
- 2011
- Full Text
- View/download PDF
21. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo.
- Author
-
Jasuja R, Furie B, and Furie BC
- Subjects
- Animals, Cell Line, Cytosol ultrastructure, Endothelial Cells cytology, Endothelial Cells ultrastructure, Endothelium metabolism, Fibrin metabolism, Humans, Mice, Mice, Inbred C57BL, Protein Disulfide-Isomerases analysis, Blood Platelets metabolism, Endothelial Cells metabolism, Protein Disulfide-Isomerases metabolism, Thrombosis metabolism
- Abstract
Protein disulfide isomerase (PDI) catalyzes the oxidation reduction and isomerization of disulfide bonds. We have previously identified an important role for extracellular PDI during thrombus formation in vivo. Here, we show that endothelial cells are a critical cellular source of secreted PDI, important for fibrin generation and platelet accumulation in vivo. Functional PDI is rapidly secreted from human umbilical vein endothelial cells in culture upon activation with thrombin or after laser-induced stimulation. PDI is localized in different cellular compartments in activated and quiescent endothelial cells, and is redistributed to the plasma membrane after cell activation. In vivo studies using intravital microscopy show that PDI appears rapidly after laser-induced vessel wall injury, before the appearance of the platelet thrombus. If platelet thrombus formation is inhibited by the infusion of eptifibatide into the circulation, PDI is detected after vessel wall injury, and fibrin deposition is normal. Treatment of mice with a function blocking anti-PDI antibody completely inhibits fibrin generation in eptifibatide-treated mice. These results indicate that, although both platelets and endothelial cells secrete PDI after laser-induced injury, PDI from endothelial cells is required for fibrin generation in vivo.
- Published
- 2010
- Full Text
- View/download PDF
22. Laser-induced endothelial cell activation supports fibrin formation.
- Author
-
Atkinson BT, Jasuja R, Chen VM, Nandivada P, Furie B, and Furie BC
- Subjects
- Animals, Blood Platelets metabolism, Cell Line, Endothelial Cells radiation effects, Endothelium, Vascular metabolism, Endothelium, Vascular radiation effects, Humans, Lasers, Mice, Mice, Inbred C57BL, Calcium metabolism, Endothelial Cells metabolism, Endothelium, Vascular injuries, Fibrin metabolism, Thrombosis
- Abstract
Laser-induced vessel wall injury leads to rapid thrombus formation in an animal thrombosis model. The target of laser injury is the endothelium. We monitored calcium mobilization to assess activation of the laser-targeted cells. Infusion of Fluo-4 AM, a calcium-sensitive fluorochrome, into the mouse circulation resulted in dye uptake in the endothelium and circulating hematopoietic cells. Laser injury in mice treated with eptifibatide to inhibit platelet accumulation resulted in rapid calcium mobilization within the endothelium. Calcium mobilization correlated with the secretion of lysosomal-associated membrane protein 1, a marker of endothelium activation. In the absence of eptifibatide, endothelium activation preceded platelet accumulation. Laser activation of human umbilical vein endothelial cells loaded with Fluo-4 resulted in a rapid increase in calcium mobilization associated cell fluorescence similar to that induced by adenosine diphosphate (10 μM) or thrombin (1 U/mL). Laser activation of human umbilical vein endothelial cells in the presence of corn trypsin inhibitor treated human plasma devoid of platelets and cell microparticles led to fibrin formation that was inhibited by an inhibitory monoclonal anti-tissue factor antibody. Thus laser injury leads to rapid endothelial cell activation. The laser activated endothelial cells can support formation of tenase and prothrombinase and may be a source of activated tissue factor as well.
- Published
- 2010
- Full Text
- View/download PDF
23. Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII.
- Author
-
Lin L, Huai Q, Huang M, Furie B, and Furie BC
- Subjects
- Amino Acid Motifs, Amino Acid Sequence, Animals, Cattle, Crystallography, X-Ray, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Alignment, Surface Properties, Cell Membrane metabolism, Factor V chemistry, Factor VIII chemistry, Milk Proteins chemistry, Structural Homology, Protein
- Abstract
Lactadherin, a glycoprotein secreted by a variety of cell types, contains two EGF domains and two C domains with sequence homology to the C domains of blood coagulation proteins factor V and factor VIII. Like these proteins, lactadherin binds to phosphatidylserine (PS)-containing membranes with high affinity. We determined the crystal structure of the bovine lactadherin C2 domain (residues 1 to 158) at 2.4 A. The lactadherin C2 structure is similar to the C2 domains of factors V and VIII (rmsd of C(alpha) atoms of 0.9 A and 1.2 A, and sequence identities of 43% and 38%, respectively). The lactadherin C2 domain has a discoidin-like fold containing two beta-sheets of five and three antiparallel beta-strands packed against one another. The N and C termini are linked by a disulfide bridge between Cys1 and Cys158. One beta-turn and two loops containing solvent-exposed hydrophobic residues extend from the C2 domain beta-sandwich core. In analogy with the C2 domains of factors V and VIII, some or all of these solvent-exposed hydrophobic residues, Trp26, Leu28, Phe31, and Phe81, likely participate in membrane binding. The C2 domain of lactadherin may serve as a marker of cell surface phosphatidylserine exposure and may have potential as a unique anti-thrombotic agent.
- Published
- 2007
- Full Text
- View/download PDF
24. Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase.
- Author
-
Zhu A, Sun H, Raymond RM Jr, Furie BC, Furie B, Bronstein M, Kaufman RJ, Westrick R, and Ginsburg D
- Subjects
- Abdomen pathology, Animals, Blood Coagulation Factors metabolism, Carbon-Carbon Ligases metabolism, Hemorrhage enzymology, Mice, Mice, Mutant Strains, Phenotype, Survival Rate, Carbon-Carbon Ligases deficiency, Hemorrhage etiology
- Abstract
The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation. Heterozygous mice carrying a null mutation at the gamma-carboxylase (Ggcx) gene exhibit normal development and survival with no evidence of hemorrhage and normal functional activity of the vitamin K-dependent clotting factors IX, X, and prothrombin. Analysis of a Ggcx(+/-) intercross revealed a partial developmental block with only 50% of expected Ggcx(-/-) offspring surviving to term, with the latter animals dying uniformly at birth of massive intra-abdominal hemorrhage. This phenotype closely resembles the partial midembryonic loss and postnatal hemorrhage previously reported for both prothrombin- and factor V (F5)-deficient mice. These data exclude the existence of a redundant carboxylase pathway and suggest that functionally critical substrates for gamma-carboxylation, at least in the developing embryo and neonate, are primarily restricted to components of the blood coagulation cascade.
- Published
- 2007
- Full Text
- View/download PDF
25. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo.
- Author
-
Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, and Furie BC
- Subjects
- Animals, Chlorides, Ferric Compounds toxicity, Hirudins pharmacology, Lasers, Mice, Mice, Knockout, Platelet Membrane Glycoproteins deficiency, Radionuclide Imaging, Receptors, IgG deficiency, Receptors, IgG genetics, Recombinant Proteins pharmacology, Thrombosis chemically induced, Thrombosis diagnostic imaging, Platelet Membrane Glycoproteins physiology, Thrombosis physiopathology
- Abstract
The role of the collagen receptor glycoprotein VI (GPVI) in arteriolar thrombus formation was studied in FcRgamma-null mice (FcRgamma(-/-)) lacking platelet surface GPVI. Thrombi were induced with severe or mild FeCl(3) injury. Collagen exposure was significantly delayed and diminished in mild compared with severe FeCl(3) injury. Times to initial thrombus formation and vessel occlusion were delayed in FcRgamma(-/-) compared with wild-type mice after severe injury. Platelet accumulation in wild-type mice was decreased after mild compared with severe injury. However, there was little difference between platelet accumulation after severe or mild injury in FcRgamma(-/-). These data indicate a significant role for GPVI in FeCl(3)-induced thrombus formation. Pretreatment of wild-type mice with lepirudin further impaired mild FeCl(3)-induced thrombus formation, demonstrating a role for thrombin. Laser-induced thrombus formation in wild-type and FcRgamma(-/-) was comparable. Collagen exposure to circulating blood was undetectable after laser injury. Normalized for thrombus size, thrombus-associated tissue factor was 5-fold higher in laser-induced thrombi than in severe FeCl(3)-induced thrombi. Thus, platelet activation by thrombin appears to be more important after laser injury than platelet activation by GPVI-collagen. It may thus be important when considering targets for antithrombotic therapy to use multiple animal models with diverse pathways to thrombus formation.
- Published
- 2006
- Full Text
- View/download PDF
26. Platelet PECAM-1 inhibits thrombus formation in vivo.
- Author
-
Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, Newman PJ, Furie BC, Furie B, and Gibbins JM
- Subjects
- Animals, Bone Marrow growth & development, Bone Marrow metabolism, Carotid Arteries cytology, Carotid Arteries metabolism, Chlorides, Female, Ferric Compounds toxicity, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Platelet Endothelial Cell Adhesion Molecule-1 genetics, Thrombosis chemically induced, Time Factors, Blood Coagulation, Blood Platelets metabolism, Platelet Endothelial Cell Adhesion Molecule-1 physiology, Thrombosis prevention & control
- Abstract
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a cell surface glycoprotein receptor expressed on a range of blood cells, including platelets, and on vascular endothelial cells. PECAM-1 possesses adhesive and signaling properties, the latter being mediated by immunoreceptor tyrosine-based inhibitory motifs present on the cytoplasmic tail of the protein. Recent studies in vitro have demonstrated that PECAM-1 signaling inhibits the aggregation of platelets. In the present study we have used PECAM-1-deficient mice and radiation chimeras to investigate the function of this receptor in the regulation of thrombus formation. Using intravital microscopy and laser-induced injury to cremaster muscle arterioles, we show that thrombi formed in PECAM-1-deficient mice were larger, formed more rapidly than in control mice, and were more stable. Larger thrombi were also formed in control mice that received transplants of PECAM-1-deficient bone marrow, in comparison to mice that received control transplants. A ferric chloride model of thrombosis was used to investigate thrombus formation in carotid arteries. In PECAM-1-deficient mice the time to 75% vessel occlusion was significantly shorter than in control mice. These data provide evidence for the involvement of platelet PECAM-1 in the negative regulation of thrombus formation.
- Published
- 2006
- Full Text
- View/download PDF
27. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.
- Author
-
Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, and Furie B
- Subjects
- Animals, Bone Marrow Transplantation, Female, Male, Mice, Mice, Inbred C57BL, Particle Size, Thromboplastin genetics, Thrombosis physiopathology, Transplantation Chimera, Bone Marrow Cells metabolism, Fibrin metabolism, Thromboplastin metabolism, Thrombosis metabolism
- Abstract
Tissue factor (TF) is expressed on nonvascular cells and cells within the vessel wall and circulates in blood associated with microparticles. Although blood-borne TF accumulates into the developing thrombus during thrombus formation, the contribution of blood-borne TF and vessel wall TF to thrombin generation in vivo following vessel injury is unknown. To determine the source and role of blood-borne microparticle TF, we studied arterial thrombus formation in a living mouse using intravital microscopy. Platelet, TF, and fibrin accumulation in the developing thrombus was compared in wild-type and low TF mice. Compared to wild-type mice, low TF mice formed very small platelet thrombi lacking TF or fibrin. Wild-type and low TF mice received transplants of bone marrow from wild-type and low TF mice. Arterial thrombi in low TF bone marrow/wild-type chimeric mice had decreased size and decreased TF and fibrin levels. Arterial thrombi in wild-type bone marrow/low TF chimeric mice showed decreased platelet thrombus size but normal TF and fibrin levels. This demonstrates that blood-borne TF associated with hematopoietic cell-derived microparticles contributes to thrombus propagation.
- Published
- 2004
- Full Text
- View/download PDF
28. Isolation and characterization of three novel Gla-containing Conus marmoreus venom peptides, one with a novel cysteine pattern.
- Author
-
Hansson K, Furie B, Furie BC, and Stenflo J
- Subjects
- 1-Carboxyglutamic Acid metabolism, Amino Acid Sequence, Animals, Molecular Sequence Data, Molecular Weight, Protein Processing, Post-Translational, Sequence Alignment, Sequence Homology, Amino Acid, Snails, Spectrometry, Mass, Electrospray Ionization, 1-Carboxyglutamic Acid chemistry, Conotoxins chemistry, Conotoxins genetics, Cysteine, Mollusk Venoms chemistry, Mollusk Venoms genetics, Peptides chemistry, Peptides genetics
- Abstract
One defining characteristic of Conus venom peptides is the high frequency of posttranslational modifications found. We report the discovery and initial characterization of three novel gamma-carboxyglutamic acid (Gla)-containing conotoxins, Gla-MrII, Gla-MrIII, and Gla-MrIV, isolated from the venom of the mollusc-hunting cone snail Conus marmoreus. Peptide Gla-MrII, a 50 amino acid residue peptide, carries eight cysteine residues arranged in a novel cysteine pattern, and five gamma-carboxyglutamic acid residues. The monoisotopic molecular mass was determined by electrospray ionization mass spectrometry to 5860.23 Da, consistent with the peptide having the cysteine residues disulphide-bonded and having a free acid C-terminus. Peptides Gla-MrIII and Gla-MrIV each contain two gamma-carboxyglutamic acid residues and share little sequence similarity to previously identified conotoxins. Both peptides contain four cysteine residues that are positioned in the linear sequence in a manner reminiscent of conotoxins belonging to cysteine scaffold superfamily T (scaffold T-1). Determination of the monoisotopic molecular masses revealed that Gla-MrIII is amidated at its C-terminus while Gla-MrIV has a free C-terminal acid.
- Published
- 2004
- Full Text
- View/download PDF
29. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels.
- Author
-
Sim DS, Merrill-Skoloff G, Furie BC, Furie B, and Flaumenhaft R
- Subjects
- 3',5'-Cyclic-AMP Phosphodiesterases antagonists & inhibitors, Animals, Cilostazol, Cyclic Nucleotide Phosphodiesterases, Type 3, Humans, Kinetics, Mice, Mice, Inbred C57BL, Phosphodiesterase Inhibitors pharmacology, Pyridazines chemistry, Tetrazoles pharmacology, Thrombosis physiopathology, Blood Platelets metabolism, Cyclic AMP metabolism, Platelet Adhesiveness drug effects, Platelet Adhesiveness physiology, Pyridazines pharmacology, Thrombosis metabolism
- Abstract
Platelet accumulation at sites of vascular injury is the primary event in arterial thrombosis. Initial platelet accrual into thrombi is mediated by interactions of platelet adhesion receptors with ligands on the injured endothelium or in the sub-endothelial matrix. The role of intracellular signals in initial platelet accumulation at sites of endothelial injury, however, is the subject of debate. We have used a newly discovered inhibitor of phosphodiesterase 3A (PDE3A) and the well-characterized PDE3A inhibitor, cilostazol, to modulate 3',5'-cyclic adenosine monophosphate (cAMP) levels in an in vivo model that enables the kinetic analysis of platelet accumulation. These studies demonstrate that elevation of basal cAMP levels results in an overall decline in platelet accumulation at the site of vascular injury. In particular, the initial rate of accumulation of platelets is inhibited by elevation of cAMP. Analysis of the kinetics of individual platelets at injury sites using intravital microscopy demonstrates that cAMP directs the rate at which platelets attach to and detach from thrombi. These studies demonstrate that cAMP in circulating platelets controls attachment to and detachment from sites of arteriolar injury. Thus, the status of the intracellular signaling machinery prior to engagement of platelet receptors influences the rate of platelet accumulation during thrombus formation.
- Published
- 2004
- Full Text
- View/download PDF
30. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin.
- Author
-
Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, and Frenette PS
- Subjects
- Animals, Bone Marrow blood supply, Bone Marrow radiation effects, Bone Marrow Cells cytology, Bone Marrow Cells physiology, Cell Division physiology, Cell Movement physiology, Endothelium, Vascular metabolism, Endothelium, Vascular radiation effects, Female, Hematopoietic Stem Cells cytology, Leukocytes cytology, Leukocytes physiology, Ligands, Male, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Microcirculation physiology, Whole-Body Irradiation, E-Selectin genetics, E-Selectin metabolism, Hematopoietic Stem Cells physiology, Integrin alpha4 metabolism, Membrane Glycoproteins genetics, Membrane Glycoproteins metabolism
- Abstract
The nature and exact function of selectin ligands involved in hematopoietic progenitor cell (HPC) homing to the bone marrow (BM) are unclear. Using murine progenitor homing assays in lethally irradiated recipients, we found that the P-selectin glycoprotein ligand-1 (PSGL-1) plays a partial role in HPC homing to the BM (a reduction of about 35% when the P-selectin binding region is blocked). Blockade of both PSGL-1 and alpha4 integrin did not further enhance the effect of anti-alpha4 integrin (a reduction of about 55%). We suspected that E-selectin ligands might contribute to the remaining homing activity. To test this hypothesis, HPC homing assays were carried out in E-selectin-deficient recipients and revealed a profound alteration in HPC homing when E-selectin and alpha4 integrin were inactivated (> 90% reduction). Competitive assays to test homing of long-term repopulating stem cells revealed a drastic reduction (> 99%) of the homed stem cell activity when both alpha4 integrin and E-selectin functions were absent. Further homing studies with PSGL-1-deficient HPCs pretreated with anti-alpha4 integrin antibody revealed that PSGL-1 contributes to approximately 60% of E-selectin ligand-mediated homing activity. Our results thus underscore a major difference between mature myeloid cells and immature stem/progenitor cells in that E-selectin ligands cooperate with alpha4 integrin rather than P-selectin ligands.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.